Ajanta Pharma Ltd.
| BSE: 532331 | Sector: Health care |
| NSE: AJANTPHARM | ISIN Code: INE031B01049 |
| BSE 12:17 | 25 May | 1701.00 |
1.70 (0.10%) |
OPEN
1703.35 |
HIGH
1703.35 |
LOW
1669.30 |
| NSE 12:04 | 25 May | 1701.75 |
1.35 (0.08%) |
OPEN
1709.30 |
HIGH
1709.30 |
LOW
1668.55 |
| OPEN | 1703.35 |
| PREVIOUS CLOSE | 1699.30 |
| VOLUME | 1520 |
| 52-Week high | 2420.00 |
| 52-Week low | 1593.30 |
| P/E | 20.18 |
| Mkt Cap.(Rs cr) | 14,527 |
| Buy Price | 1699.15 |
| Buy Qty | 1.00 |
| Sell Price | 1701.00 |
| Sell Qty | 1.00 |
Ajanta Pharma Ltd. (AJANTPHARM) - Latest News & Headlines
-
Bonus issue fails to lift Ajanta Pharma; stock hits 52-week low on weak Q4
12.27 pm | 11 May 2022 | Business Standard
In Q4FY22, Ajanta's earnings before interest, taxes, depreciation, and amortization declined 20 per cent year-on- year to Rs 207 crore.
-
Ajanta Pharma gains 5% on share buyback plan, board to meet on Dec 28
11.27 am | 24 Dec 2021 | Business Standard
The board of directors of the company is scheduled to consider a proposal for buy-back of equity shares on Tuesday, December 28.
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
